The US Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines.
The Department of Health says there is "no shortage" of Pfizer COVID-19 vaccines in New Brunswick, but with holiday ...
The drop reflects investors reactions to Pfizer’s new 2026 revenue forecasts, which is set to be between the range of $59.5 billion to $62.5 billion, a decline of $1.5 billion from 2025’s estimated ...
7hOpinion
EXCLUSIVE: Ron Johnson Demands Docs After ‘Blockbuster’ FDA Memo Links Child Deaths To COVID Vaccine
Sen. Ron Johnson said in a letter Monday that he will continue to push for documents about deaths following the COVID-19 ...
While you're collecting healthy dividends, you'll also benefit from the price-to-earnings (P/E) ratio expanding when revenue ...
Eli Lilly’s retatrutide exceeds expectations in Phase III, capping off a sparkling 2025 for the obesity titan; an internal ...
Pfizer (PFE) stock is in focus as the firm with Astellas (ALPMF) post a Phase 3 trial win for Padcev cancer drug when used ...
A reported personal case highlights how a rare vaccine side effect led to the hospitalisation of a previously healthy 24-year ...
Pfizer ( (PFE)) has provided an announcement. On December 16, 2025, Pfizer announced its financial guidance for the full year 2026, while revising its 2025 revenue guidance to approximately $62.0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results